Abterra Biosciences performed NGS sequencing and analysis on llama PBMCs and the VHH library constructed from the same material to compare CDR3 lengths, mutation distributions, primer bias, and germline gene usage.

Abterra Bio is enabling the next-generation of antibody therapeutics. Our technologies use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response to challenge. We give our partners access to every relevant antibody to meet their project goals. Find out what service might be right for you with our service guide: https://abterrabio.com/service-guide/ Abterra Bio began life as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna are professors in the Computer Science and Engineering Department and leading researchers in bioinformatics. Their expertise forms the algorithmic foundation upon which our products and services are built.